Clyz Labs Raises Seed Funding

▤ Summary

Clyz Labs , a Manchester UK-based early-stage cancer diagnostics company, raised a seed funding of undisclosed amount.Catapult Ventures made the investment through the GM&C Life Sciences Fund.The company intends to use the funds to further optimize and validate the Cancertain™ Assay in patients with lung cancer and to generate much needed evidence in a clinical setting.Founded in 2017 and led by Dr Himanshu Kataria, Director, Clyz is developing the Cancertain™ Assay as a service to select the best drug therapy for personalised cancer treatment.The company is advancing the first clinical trial involving its test, which has already secured all regulatory approvals.

▦ Linked Companies